There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
-
In trial, 82% saw weight rebound and cardiovascular health reverse after
withdrawal.
Unknown
DeveloperCras justo odio, dapibus ac facilisis in, egestas eget quam. Curabitur blandit tempus porttitor. Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor.

0 comments:
Post a Comment